Our Symposium Co-Chairs

Jonathan Lai

Jonathan Lai, Ph.D. - Co Chair

Department of Biochemistry
Albert Einstein College of Medicine
jon.lai@einstein.yu.edu

 

Jonathan Lai received his B. Sc. Hons. in Biochemistry from Queen’s University in Kingston, Ontario, Canada in 1999. One of his first experiences with laboratory science was a summer research project purifying natural product antibiotics in Prof. John Vederas's lab at the University of Alberta in 1997. He received his Ph.D. in Biophysics and Chemistry in 2004 with Prof. Samuel H. Gellman at the University of Wisconsin where he studied peptide structure, function, and engineering as a Canadian National Sciences and Engineering Research Council Scholar.

From 2004-2007, he was Helen Hay Whitney Post-Doctoral Fellow with Prof. Christopher T. Walsh in Biological Chemistry at Harvard Medical School where he worked on the structure, function, and engineering of non-ribosomal peptide synthetase assembly line enzymes. In 2007 he completed an additional post-doctoral fellowship with Prof. Stephen C. Harrison at Harvard where he focused on structural virology and X-ray crystallography. He began his independent career at the Albert Einstein College of Medicine in 2007, where he is currently Associate Professor of Biochemistry.

His lab has worked on a broad range of topics in peptide and protein structure, function, and engineering for biomedical applications. His group has defined the role of pH-dependent conformational changes in viral glycoproteins for the entry mechanisms of Ebola, Marburg, and arenaviruses. In addition Dr. Lai described the first and only human scaffold protective antibodies against the Sudan virus, and the first engineered cross-protective filovirus antibodies. His work has resulted in over 40 peer-reviewed publications and 8 patent applications. He was recipient of the Arnold and Mabel Beckman Foundation Young Investigator Award in 2009 and the Irma T. Hirschl/Monique Weill-Caulier Career Scientist Award in 2015

John C. Vederas

John Vederas, Ph.D., Co Chair

Department of Chemistry
University of Alberta
john.vederas@ualberta.ca

 

John C. Vederas is Distinguished University Professor of Chemistry since June 2000 at the University of Alberta. He obtained a B.Sc. in Chemistry from Stanford University and a Ph.D. in Organic Chemistry, synthesis, with the late George Büchi from the Massachusetts Institute of Technology. His postdoctoral work at the University of Basel, with Christoph Tamm, and at Purdue University, with Heinz Floss, inspired a continuing interest in application of organic chemistry to understanding of biological mechanisms, especially in polyketide and peptide biosynthesis.

He joined the University of Alberta as an Assistant Professor in 1977 and subsequently held the Canada Research Chair in Bioorganic and Medicinal Chemistry from 2001 to 2015. He has received recognition for research and teaching from the University of Alberta, including the Rutherford Award for Excellence in Undergraduate Teaching, the University Cup for Research and Teaching, the J. Gordin Kaplan Award for Excellence in Research, the Killam Award for Excellence in Mentoring, and the Klawe Prize in Teaching Large Classes.

John is a Fellow of the Royal Society of Canada and an Alberta Centennial Medal recipient. He has received the Merck Sharp Dohme Award, the John Labatt Award, the R. U. Lemieux Award, and the Alfred Bader Award from the Canadian Society for Chemistry for his research. In 2008 he was awarded the Chemical Institute of Canada Medal, the society's highest honor, and in 2009 he was elected a Fellow of the Royal Society, London. He received the 2010 Leadership in Science Award from the Alberta Science & Technology Foundation. In 2014 he was made a Fellow of the American Academy of Microbiology. He served in numerous scientific organizations, was President of the Canadian Society for Chemistry, 2002-2003, a Member of Council of the Natural Sciences and Engineering Research Council of Canada, Chair of the 2008 Annual Conference of the Canadian Society for Chemistry, and Chair of the Chemical Institute of Canada for 2015-2016.

 

Our Sponsors

  • IPSENIpsen US, comprised of Ipsen Biopharmaceuticals, Inc., and Ipsen Bioscience, Inc., is driven by a passion to improve the lives of patients. A search for innovative solutions to disabling conditions is at the heart of everything we do. We are inspired to find effective therapeutic options to treat diseases, relieve suffering, and bring value to the community.
  • BACHEMBachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry.
  • BiotageBiotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification.
  • FERRINGFerring Pharmaceuticals Inc. is a research-driven biopharmaceutical company devoted to commercialization of innovative products in the fields of infertility and reproductive health, gastroenterology, gynecology, orthopaedics and urology.
  • Gyros Protein TechnologiesExpertise and deep knowledge in providing peptide synthesis and bioanalytical tools
  • POLYPEP_logoAt PolyPeptide, going the extra mile with our customers is a priority. Agility, global presence, flexibility, ability to create fast-tailored solutions, and exceeding the highest requirements, are all key benefits that you could only expect from a world leader in peptide manufacturing.
  • Reflexion_logo
  • SANOFISanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
  • ZEAL&_logoZealand Pharma is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi, Boehringer Ingelheim and Helsinn and a pipeline of proprietary product candidates, which primarily target specialty diseases with significant unmet needs.
  • CPC ScientificCPC Scientific is a global provider of high-quality cGMP and custom peptides to researchers and pharmaceutical companies.
  • DaisogelDAISO offers you highly reproducible and predictable DAISOGEL® analytical and preparative columns for proteins, peptides, and organic compounds.
  • InterchimWe manufacture and distribute consumables and instruments for research and industry.
  • Novo NordiskNovo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
  • AMGENAmgen is one of the world’s leading biotechnology companies.
  • CBL PharmaChemical and Biopharmaceutical Laboratories is a global peptide manufacturing technology company founded in 1990 to provide the industry with novel chemistries in key areas of solid phase peptide and organic synthesis.
  • CEMCEM Corporation, a private company based in Matthews, North Carolina, is the leading provider of microwave laboratory instrumentation.
  • ChemPepChemPep®, a bioscience company located in Wellington, Florida, provides innovative products and services for R&D in the areas of organic chemistry, biochemistry, molecular biology, solid phase synthesis, peptide and combinatorial chemistry.
  • Intarcia TherapeuticsIntarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies utilizing the Medici Drug Delivery System™ - medicines that have the potential to transform the prevention and management of serious chronic diseases.
  • merck_logoWe are a global healthcare company with a 125-year history of working to make a difference.
  • PEPTIDES INTERNATIONALPeptides International manufactures and distributes a wide variety of products that are used in major research institutions throughout the world.
  • peptide_science_logoThe aim of Peptide Science is to publish significant original research papers and comprehensive reviews covering the whole spectrum of peptide science including synthesis, structure and bioactivity.
  • PfizerWith 25,000 researchers testing 8000 new compounds every year, our science is our foundation. It is created by our people, drives our purpose, and creates our products.
  • Ra PharmaRa Pharma® utilizes a process called “mRNA display” and the Extreme Diversity™ platform to produce extremely large and diverse libraries of peptides from which to screen for potential product candidates.
  • scilligence_logoScilligence facilitates Science with Intelligence
  • Bioconjugate ScienceBioconjugate Chemistry invites original contributions on all research at the interface between man-made and biological materials.
  • ACS Combinatorial ScienceACS Combinatorial Science publishes research describing the development and use of combinatorial, high-throughput, and related methods in chemistry, materials science, and biology.
Logo